202306 Improvement Programmes Network Conference Cpd Learning

Leading Improvement

Since 2019, our short programmes have developed 176 clinicians; impacting nearly 60,000 patients, their families and numerous Trusts all over the UK.

Our short programmes are a fundamental area of our work. They give us the chance to deliver material to target specific areas of the pathway and reach more patients. Our redesigned format run on a 20 week basis and will support you in mobilising change within your organisation. 

Upcoming activity

Submit an application for our upcoming programmes:

Urology Clinical Leads

We have launched this programme for the fourth year running. We are actively recruiting Urology Clinical Leads who want to build and develop their leadership skills.
Urology Clinical Leads Programme

Primary Care Programme

We are opening applications for a short programme aimed at the primary care network. We are currently refining this programme but are looking at taking applications in early 2024. Use the link below to register your interest.
Register my interest

Change and Innovators Programme

Following the success of 2023's cohort, we are going to run our Change and Innovators programme again in 2024.  Submit your details below to be alerted to when we open recruitment.
Change and Innovators Programme

Sexual Wellbeing programme

We are looking to run a programme focussing on best practice in supporting patients with improving Sexual Wellbeing. This programme will run in late 2024 but please register your interest below to find out more at a later date.
Notify me
202306 Improvement Programmes Imperial War Museum Group Conference Network

Current short programme:

We are currently running our Change and Innovators Programme, which is supporting those working in and alongside the prostate cancer pathway to develop and construct their leaderships skills to become changemakers and innovators. 

Our fantastic participants recently attended module three where we pitched ideas and projects through different communication styles. This day will help our change-makers deliver powerful, effective messages to stakeholders. 

We are looking forward to module 4 in October where we will evaluate projects and reflect upon our progress and development. 

The History of our Short Programmes

The Improvement Programmes Team was created by Prostate Cancer UK in 2019. The first two years, we delivered three programmes- Supported Self Management, Clinical Leads (in collaboration with BAUS) and Advanced Disease. These programmes improved prostate cancer care for over 14,000 men. 

Due to the impact of the pandemic, Clinical Leads was the only short programme to go ahead in 2021. As a direct result of this programme, over 11,000 patients will have experienced an improvement in quality of prostate cancer care. 

Read below to find out more about our most recent impact from our 2022 programmes. 

Our 2022 impact

We had 55 clinicians join our short programmes in 2022, they will collectively change the prostate cancer pathway for nearly 18,000 men.

202306 Improvement Programmes Chart Learning Conference

Living and Dying Well with advanced prostate cancer

This programme supported clinicians in navigating challenges that exist in palliative and end of life care. Over 2,000 patients will benefit from this programme.

202306 Improvement Programme Network Conference Cpd Learning Teach

Patient Recorded Outcome Measures (PROMS)

This programme explored using proven measurement methods (PROMS, HNAs + QOL) to improve the quality and appropriateness of individual patient care. Over 6,280 patients will be directly impacted by this programme.

202306 Improvement Programmes Network Conference Cpd Learning

Clinical Leads 2022

This programme developed Clinical Leads in challenging them to lead change from within to create development in their Trusts. More than 9,000 patients have benefitted from their projects.

If you'd like to discuss our short programmes, please contact the Improvement Programmes Team.


Our Prostate Cancer UK Improvement Programmes are partly funded by grants from Astellas Pharma Ltd, Bayer UK and Roche Products Ltd. However, none of these organisations have any influence over the educational content of the programmes.